Halozyme Therapeutics, Inc. (HALO)

CIK 1159036 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for Halozyme Therapeutics, Inc..

Recent SEC filings

FiledFormAccession number
Nov 5, 20268-K0001159036-26-000143
Nov 5, 202610-Q0001159036-26-000145
Oct 8, 20264/A0001159036-26-000139
Oct 8, 202640001159036-26-000140
Oct 2, 202630001159036-26-000135
Oct 2, 202640001159036-26-000136
Oct 2, 202640001159036-26-000133
Sep 30, 20268-K0001159036-26-000128
Sep 22, 20268-K0001193125-26-398015
Sep 18, 20268-K0001159036-26-000126
Sep 17, 202640001159036-26-000123
Sep 16, 20261440001950047-26-009587
Sep 16, 20268-K0001159036-26-000121
Sep 11, 202640001159036-26-000119
Sep 2, 202640001159036-26-000117
Aug 21, 202630001159036-26-000115
Aug 19, 202640001159036-26-000108
Aug 18, 20268-K0001159036-26-000106
Aug 17, 20261440001968582-26-000846
Aug 11, 202640001662521-26-000002
Aug 11, 20261440001950047-26-007986
Aug 10, 20261440001950047-26-007890
Aug 6, 20268-K0001159036-26-000103
Aug 6, 202610-Q0001159036-26-000104
Jul 9, 202640001159036-26-000100